Stay updated on BOS-580 in NASH Obese Subjects Clinical Trial
Sign up to get notified when there's something new on the BOS-580 in NASH Obese Subjects Clinical Trial page.

Latest updates to the BOS-580 in NASH Obese Subjects Clinical Trial page
- Check6 days agoChange DetectedThe page revision indicator was updated from v3.5.3 to v3.5.4. This appears to be a backend/UI version update without changing the study details or visible content.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page revision has been updated to v3.5.3, indicating a small system update to the page formatting. No substantive study information appears to have changed.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 in the page footer; this is an administrative version change with no changes to study content.SummaryDifference0.0%

- Check42 days agoChange DetectedRemoved related topic links for Non-alcoholic fatty liver disease and MedlinePlus Genetics from the related topics section.SummaryDifference0.1%

- Check56 days agoChange DetectedAdded related topics: Non-alcoholic fatty liver disease and MedlinePlus Genetics to the page’s related topics section.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded: a new Lancet article citation for Efimosfermin BOS-580 (2026). Deleted: older related topics entry and an earlier Lancet preprint citation.SummaryDifference0.2%

Stay in the know with updates to BOS-580 in NASH Obese Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BOS-580 in NASH Obese Subjects Clinical Trial page.